The Company’s Charters and Policies, ASX announcements, and News
This Corporate Governance Statement was approved by the Board of Directors and is current as at 27 July 2024.
TrivarX is listed on the Australian Securities Exchange (ASX) under the ticker code TRI
TrivarX is using artificial intelligence to gain sleep data, which could help with the diagnosis and better treat mental health disorders.
Sleep is often overlooked in the pursuit of health, overshadowed by nutrition and exercise, yet it is a vital foundation for well-being, according to experts.
TechInvest Magazine features the 2024 TechKnow Invest Roadshow Conference Q&A with Kai Sun of TrivarX.
TrivarX is commercialising its AI-driven screening and diagnostic tools to assist in the screening and long-term monitoring of mental illness and mood disorders.